Literature DB >> 15467323

Exhaled nitric oxide and hydrogen peroxide concentrations in asthmatic smokers.

Ildikó Horváth1, Louise E Donnelly, András Kiss, Beata Balint, Sergei A Kharitonov, Peter J Barnes.   

Abstract

BACKGROUND: Cigarette smoking is associated with decreased nitric oxide (NO) production and increased oxidative stress in the airways. Exhaled NO levels are not higher in asthmatic smokers than in healthy non-smokers, and the value of exhaled NO for diagnosing asthma in smokers has been questioned.
OBJECTIVES: To compare exhaled NO concentrations between healthy and steroid-naive and steroid-treated asthmatic smokers and non-smokers. To also assess the acute effect of cigarette smoking on exhaled NO and hydrogen peroxide (H(2)O(2)) levels in asthmatic smokers.
METHODS: Exhaled NO was measured by chemiluminescence and exhaled H(2)O(2) spectrophotometrically. In 7 steroid-naive asthmatic smokers exhaled NO and H(2)O(2) was measured both before and 15 min after smoking one cigarette. Data are given as median (range).
RESULTS: Exhaled NO level was significantly higher in steroid-naive asthmatic smokers than in healthy smokers [7.7 (3.4-32.5) ppb vs. 3.2 (2.0-7.2) ppb, p < 0.001]. Exhaled NO values were lower in smokers than in non-smokers both in healthy subjects and in steroid-naive asthmatic patients. Steroid-treated asthmatic smokers had a tendency for lower exhaled NO values [5.4 (1.7-12.0) ppb] compared to steroid-naive asthmatic smokers. Cigarette smoking caused an acute increase in exhaled H(2)O(2) concentrations together with a decrease in exhaled NO concentration.
CONCLUSIONS: Our data suggest that an elevation in exhaled NO concentration is associated with asthma in smokers. This difference may be useful for diagnosing the disease in smokers, but its clinical value needs further evaluation. Acute increase in exhaled H(2)O(2) concentrations suggests that smoking increases the oxidative stress in the asthmatic airways.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15467323     DOI: 10.1159/000080630

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  14 in total

1.  Clinical study of multiple breath biomarkers of asthma and COPD (NO, CO(2), CO and N(2)O) by infrared laser spectroscopy.

Authors:  Joanne H Shorter; David D Nelson; J Barry McManus; Mark S Zahniser; Susan R Sama; Donald K Milton
Journal:  J Breath Res       Date:  2011-07-15       Impact factor: 3.262

2.  Exhaled nitric oxide in asthma: progress since the introduction of standardized methodology.

Authors:  Natalia M Grob; Raed A Dweik
Journal:  J Breath Res       Date:  2008-09       Impact factor: 3.262

Review 3.  Exhaled nitric oxide: a test for diagnosis and control of asthma?

Authors:  Rohit Katial; Lora Stewart
Journal:  Curr Allergy Asthma Rep       Date:  2007-11       Impact factor: 4.806

4.  Non-invasive evaluation of pulmonary glutathione in the exhaled breath condensate of otherwise healthy alcoholics.

Authors:  Mary Y Yeh; Ellen L Burnham; Marc Moss; Lou Ann S Brown
Journal:  Respir Med       Date:  2007-10-30       Impact factor: 3.415

5.  Exposure to cigarette smoke impacts myeloid-derived regulatory cell function and exacerbates airway hyper-responsiveness.

Authors:  Yong Wang; Tong Huan Jin; Aisha Farhana; Jason Freeman; Kim Estell; Jaroslaw W Zmijewski; Amit Gaggar; Victor J Thannickal; Lisa M Schwiebert; Adrie J C Steyn; Jessy S Deshane
Journal:  Lab Invest       Date:  2014-11-03       Impact factor: 5.662

6.  Does asthma control as assessed by the asthma control test reflect airway inflammation?

Authors:  Mine Bora; Aylin Ozgen Alpaydin; Arzu Yorgancioglu; Gizem Akkas; Aydın Isisag; Aysın Sakar Coskun; Pınar Celik
Journal:  Multidiscip Respir Med       Date:  2011-10-31

7.  Storage conditions for stability of offline measurement of fractional exhaled nitric oxide after collection for epidemiologic research.

Authors:  Yoshiko Yoda; Naruhito Otani; Hideki Hasunuma; Hiroshi Kanegae; Masayuki Shima
Journal:  BMC Pulm Med       Date:  2012-11-02       Impact factor: 3.317

Review 8.  Identifying targets for COPD treatment through gene expression analyses.

Authors:  Zhi-Hua Chen; Hong Pyo Kim; Stefan W Ryter; Augustine M K Choi
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

Review 9.  Airway biomarkers of the oxidant burden in asthma and chronic obstructive pulmonary disease: current and future perspectives.

Authors:  Noora Louhelainen; Marjukka Myllärniemi; Irfan Rahman; Vuokko L Kinnula
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

10.  Using fractional exhaled nitric oxide (FeNO) to diagnose steroid-responsive disease and guide asthma management in routine care.

Authors:  David Price; Dermot Ryan; Annie Burden; Julie Von Ziegenweidt; Shuna Gould; Daryl Freeman; Kevin Gruffydd-Jones; Anne Copland; Clifford Godley; Alison Chisholm; Mike Thomas
Journal:  Clin Transl Allergy       Date:  2013-11-07       Impact factor: 5.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.